Digital Aria Co Ltd Cash Flow Conversion Efficiency

Latest as of June 2026: -0.019x

Digital Aria Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Digital Aria Co Ltd (115450) has a cash flow conversion efficiency ratio of -0.019x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-3.14 Billion ≈ $-2.13 Million USD) by net assets (₩169.07 Billion ≈ $114.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Digital Aria Co Ltd (2011–2025)

Cash flow conversion efficiency of Digital Aria Co Ltd from 2011 to 2025. This chart illustrates how Digital Aria Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Digital Aria Co Ltd for real-time trading data and today's change.

Digital Aria Co Ltd Cash Flow Conversion Ratio Explained

Digital Aria Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Digital Aria Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Digital Aria Co Ltd ranked by their cash flow conversion efficiency. Also see Digital Aria Co Ltd market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Ilex Medical
TA:ILX
0.070x
Rav Bariach 08 Industries Ltd
TA:BRIH
0.076x
TTK Healthcare Limited
NSE:TTKHLTCARE
-0.020x
Warehouses Estates Belgium SCA
BR:WEB
0.031x
ABC Taiwan Electronics
TWO:3236
0.057x
HIM International Music
TWO:8446
0.018x
Whitehawk Therapeutics, Inc.
NASDAQ:WHWK
-0.098x
TIZIANA LIFE SCIENCES LTD
F:0RP
N/A

Annual Cash Flow Conversion Efficiency for Digital Aria Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Digital Aria Co Ltd from 2011 to 2025. Review 115450 FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩173.86 Billion
≈ $117.82 Million
₩-8.18 Billion
≈ $-5.54 Million
-0.047x -675.17%
2024-12-31 ₩157.46 Billion
≈ $106.71 Million
₩1.29 Billion
≈ $872.70K
0.008x -57.84%
2023-12-31 ₩171.52 Billion
≈ $116.24 Million
₩3.33 Billion
≈ $2.25 Million
0.019x +125.70%
2022-12-31 ₩116.71 Billion
≈ $79.09 Million
₩-8.81 Billion
≈ $-5.97 Million
-0.075x +20.51%
2021-12-31 ₩118.68 Billion
≈ $80.43 Million
₩-11.27 Billion
≈ $-7.64 Million
-0.095x +27.18%
2020-12-31 ₩89.35 Billion
≈ $60.55 Million
₩-11.65 Billion
≈ $-7.90 Million
-0.130x -50.39%
2019-12-31 ₩63.94 Billion
≈ $43.33 Million
₩-5.54 Billion
≈ $-3.76 Million
-0.087x -68.84%
2018-12-31 ₩68.66 Billion
≈ $46.53 Million
₩-3.53 Billion
≈ $-2.39 Million
-0.051x +57.63%
2017-12-31 ₩38.44 Billion
≈ $26.05 Million
₩-4.66 Billion
≈ $-3.16 Million
-0.121x -51.17%
2016-12-31 ₩33.88 Billion
≈ $22.96 Million
₩-2.72 Billion
≈ $-1.84 Million
-0.080x +43.87%
2015-12-31 ₩30.08 Billion
≈ $20.39 Million
₩-4.30 Billion
≈ $-2.91 Million
-0.143x +39.24%
2014-12-31 ₩22.52 Billion
≈ $15.26 Million
₩-5.29 Billion
≈ $-3.59 Million
-0.235x -327.84%
2011-12-31 ₩18.38 Billion
≈ $12.46 Million
₩1.90 Billion
≈ $1.29 Million
0.103x --

About Digital Aria Co Ltd

KQ:115450 Korea Biotechnology
Market Cap
$141.59 Million
₩208.93 Billion KRW
Market Cap Rank
#17692 Global
#747 in Korea
Share Price
₩2370.00
Change (1 day)
-7.96%
52-Week Range
₩1451.00 - ₩3980.00
All Time High
₩25764.90
About

HLB Therapeutics Co.,Ltd., a biotech company, develops pharmaceutical products in South Korea and internationally. It is developing GBT-201 using Thymosin beta for the treatment of ophthalmic diseases, such as dry eye syndrome and neurotrophic keratopathy; and OKN-007 for the treatment of glioblastoma brain tumor. It is also involved in the wholesale of vaccines, as well as manufactures electrica… Read more